StockData
FibroBiologics, Inc. logo

FibroBiologics, Inc. (FBLG) stock

FBLGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 2/30
$0.90−0.02 (-2.56%)

Close on Nov 16, 2026Market cap $6.02MP/E –Yield –

FibroBiologics total assets

Total assets on the balance sheet at the end of each period.

FibroBiologics's total assets was $7.93M at Jun 30, 2026. For fiscal 2025 it was $9.62M, down 41.5% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.62M-41.5%
FY2024Dec 31, 2024$16.45M+39.1%
FY2023Dec 31, 2023$11.82M+145.0%
FY2022Dec 31, 2022$4.82M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$7.93M-43.0%
Q1 FY2026Mar 31, 2026$5.94M-48.0%
Q4 FY2025Dec 31, 2025$9.62M-41.5%
Q3 FY2025Sep 30, 2025$8.74M-16.5%
Q2 FY2025Jun 30, 2025$13.91M+56.0%
Q1 FY2025Mar 31, 2025$11.43M+0.2%
Q4 FY2024Dec 31, 2024$16.45M+39.1%
Q3 FY2024Sep 30, 2024$10.47M+117.0%
Q2 FY2024Jun 30, 2024$8.91M–
Q1 FY2024Mar 31, 2024$11.40M–
Q4 FY2023Dec 31, 2023$11.82M–
Q4 FY2022Dec 31, 2022$4.82M–

More FibroBiologics figures

See a number that looks wrong?